Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
42 we » 42 w (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
42 we » 42 w (Expand Search)
-
601
-
602
Growth, ammonium metabolism, and photosynthetic properties of <i>Ulva australis</i> (Chlorophyta) under decreasing pH and ammonium enrichment - Fig 4
Published 2017“…<p><b>(A) Total chlorophyll (mg Chl <i>a</i> + <i>b</i> g</b><sup><b>-1</b></sup><b>FW), (B) rETR</b><sub><b>max</b></sub><b>from rapid light curves, and (C) F</b><sub><b>v</b></sub><b>/F</b><sub><b>m</b></sub><b>from rapid light curves for <i>Ulva australis</i> grown under ambient and enriched NH</b><sub><b>4</b></sub><sup><b>+</b></sup><b>treatments across a range of pH</b><sub><b>T</b></sub>. …”
-
603
-
604
-
605
Root cell wall proteins with significant decreased in expression level under 50 µM Cu treatment identified by LC-ESI-MS/MS-based proteomics using SIEVE (<i>p</i><0.05 and fold chang >1.5).
Published 2014“…</p><p>Root cell wall proteins with significant decreased in expression level under 50 µM Cu treatment identified by LC-ESI-MS/MS-based proteomics using SIEVE (<i>p</i><0.05 and fold chang >1.5).…”
-
606
-
607
-
608
-
609
-
610
-
611
-
612
-
613
-
614
-
615
-
616
-
617
Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx
Published 2022“…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”
-
618
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
619
-
620